Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carbapenem use in French hospitals: A nationwide survey at the patient level.
Gauzit R, Pean Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Robert J; Société de Pathologie Infectieuse de Langue Française (SPILF); Observatoire National de l’Épidémiologie de la Résistance Bactérienne aux Antibiotiques (ONERBA); Surveillance de la Prescription des Antibiotiques (SPA) Group. Gauzit R, et al. Int J Antimicrob Agents. 2015 Dec;46(6):707-12. doi: 10.1016/j.ijantimicag.2015.08.013. Epub 2015 Sep 30. Int J Antimicrob Agents. 2015. PMID: 26508585
Point prevalence survey of antibiotic use in French hospitals in 2009.
Robert J, Péan Y, Varon E, Bru JP, Bedos JP, Bertrand X, Lepape A, Stahl JP, Gauzit R; Société de pathologie infectieuse de langue française (SPILF); Observatoire national de l’épidémiologie de la résistance bactérienne aux antibiotiques (ONERBA); Surveillance de la prescription des antibiotiques (SPA) Group. Robert J, et al. Among authors: gauzit r. J Antimicrob Chemother. 2012 Apr;67(4):1020-6. doi: 10.1093/jac/dkr571. Epub 2012 Jan 18. J Antimicrob Chemother. 2012. PMID: 22258928
Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy.
Quenot JP, Luyt CE, Roche N, Chalumeau M, Charles PE, Claessens YE, Lasocki S, Bedos JP, Péan Y, Philippart F, Ruiz S, Gras-Leguen C, Dupuy AM, Pugin J, Stahl JP, Misset B, Gauzit R, Brun-Buisson C. Quenot JP, et al. Among authors: gauzit r. Ann Intensive Care. 2013 Jul 8;3(1):21. doi: 10.1186/2110-5820-3-21. Ann Intensive Care. 2013. PMID: 23830525 Free PMC article.
Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections.
Dupuy AM, Philippart F, Péan Y, Lasocki S, Charles PE, Chalumeau M, Claessens YE, Quenot JP, Guen CG, Ruiz S, Luyt CE, Roche N, Stahl JP, Bedos JP, Pugin J, Gauzit R, Misset B, Brun-Buisson C; Maurice Rapin Institute Biomarkers Group. Dupuy AM, et al. Among authors: gauzit r. Ann Intensive Care. 2013 Jul 9;3(1):22. doi: 10.1186/2110-5820-3-22. Ann Intensive Care. 2013. PMID: 23837559 Free PMC article.
114 results